Initial hemodialysis with a temporary catheter is associated with complications of a later permanent vascular access

Blood Purification

Volumn 37, Issue 2, 2014, Pages 131-137

  Zhu, Mingli ^a   Zhang, Weiming ^a   Zhou, Wenyan ^a   Zhou, Yijun ^a   Fang, Yan ^a   Wang, Yongmei ^a   Zhang, Haifen ^a   Yan, Yucheng ^a   Ni, Zhaohui ^a   Qian, Jiaqi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Complications; End stage renal disease; Risk factors; Temporary catheter; Vascular access for hemodialysis

Indexed keywords

ADULT; AGE; ARTERIOVENOUS FISTULA; ARTICLE; BLOOD VESSEL CATHETERIZATION; CARDIOVASCULAR INFECTION; CHRONIC GLOMERULONEPHRITIS; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIALYSIS CATHETER; END STAGE RENAL DISEASE; FALSE ANEURYSM; FEMALE; FOLLOW UP; GENDER; HEART FAILURE; HEMODIALYSIS; HUMAN; HYPERTENSION; IATROGENIC DISEASE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; NEPHROSCLEROSIS; PRIORITY JOURNAL; RISK FACTOR; RUNOFF VEIN STENOSIS; STENOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; VASCULAR ACCESS; VASCULAR DISEASE; VASCULAR PATENCY; VEIN OCCLUSION; VEIN THROMBOSIS; BODY HEIGHT; BODY MASS; BODY WEIGHT; CEREBROVASCULAR DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; SMOKING; ADVERSE EFFECTS; AGED; CATHETER; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY;

CREATININE;

ADULT; AGED; ARTERIOVENOUS FISTULA; CATHETERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84897361736     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000360269     Document Type: Article

References (40)

1. Scribner BH, Buri R, Caner JE, Hegstrom R, Burnell JM: A preliminary report. Trans Am Soc Artif Intern Organs 1960; 6: 114-122.
2. Brescia MJ, Cimino JE, Appel K, Hurwich BJ: Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 1966; 275: 1089-1092.
3. Besarab A: Resolved: fistulas are preferred to grafts as initial vascular access for dialysis. Proc J Am Soc Nephrol 2008; 19: 1629-1631.
4. NKF-K/DOQI clinical practice guidelines for vascular access: update 2006. Am J Kidney Dis 2006; 48(suppl 1):S177-S322.
5. Tordoir J, Canaud B, Haage P, Konner K, Basci A, Fouque D, Kooman J, Martin-Malo A, Pedrini L, Pizzarelli F, Tattersall J, Vennegoor M, Wanner C, ter Wee P, Vanholder R: EBPG on vascular access. Nephrol Dial Transplant 2007; 22(suppl 2):ii88-ii117.
6. Jindal K, Chan CT, Deziel C, Hirsch D, Soroka SD, Tonelli M, Culleton BF: Canadian Society of Nephrology Committee for Clinical Practice Guidelines: Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol 2006; 17(suppl 1):S1-S27.
7. Ethier J, Mendelssohn DC, Elder SJ, Hasegawa T, Akizawa T, Akiba T, Canaud BJ, Pisoni RL: Vascular access use and outcomes: an international perspective from the dialysis outcomes and practice patterns study. Nephrol Dial Transplant 2008; 23: 3219-3226.
8. Shanghai Renal Registry Network: Shanghai Dialysis Registry Annual Report, 2011. http://sh.cnrds.org.
9. Woo K, Doros G, Ng T, Farber A: Comparison of the efficacy of upper arm transposed arteriovenous fistulae and upper arm prosthetic grafts. J Vasc Surg 2009; 50: 1405-1411.
10. Hazinedaro?lu SM, Tuzuner A, Ayli D, Demirer S, Duman N, Yerdel MA: Femoral vein transposition versus femoral loop grafts for hemodialysis: a prospective evaluation. Transplant Proc 2004; 36: 65-67. (Pubitemid 38177190)
11. Pflederer TA, Kwok S, Ketel BL, Pilgram T: A comparison of transposed brachiobasilic fistulae with nontransposed fistulae and grafts in the fistula-first era. Semin Dial 2008; 21: 357-363.
12. Basel H, Ekim H, Odabasi D, Kiymaz A, Aydin C, Dostbil A: Basilic vein transposition fistulas versus prosthetic bridge grafts in patients with end-stage renal failure. Ann Vasc Surg 2011; 25: 634-639.
13. Elseviers MM, Van Waeleghem JP; European Dialysis and Transplant Nurses Association/European Renal Care Association: Identifying vascular access complications among ESRD patients in Europe. A prospective, multicenter study. Nephrol News Issues 2003; 17: 61-64, 66-68, 99.
14. Mann B, Tonelli M, Yilmaz S, Lee H, Laupland K, Klarenbach S, Radkevich V, Murphy B: Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis. J Am Soc Nephrol 2005; 16: 201-209. (Pubitemid 43073174)
15. Allon M, Robbin ML: Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int 2002; 62: 1109-1124.
16. Huijbregts HJ, Bots ML, Wittens CH, Schrama YC, Blankestijn PJ: Access blood flow and the risk of complications in mature forearm and upper arm arteriovenous fistulas. Blood Purif 2009; 27: 212-219.
17. Monroy-Cuadros M, Yilmaz S, Salazar-Banuelos A, Doig C: Risk factors associated with patency loss of hemodialysis vascular access within 6 months. Clin J Am Soc Nephrol 2010; 5: 1787-1792.
18. Arce CM, Mitani AA, Goldstein BA, Winkelmayer WC: Hispanic ethnicity and vascular access use in patients initiating hemodialysis in the United States. Clin J Am Soc Nephrol 2012; 7: 289-296.
19. Wasse H, Speckman RA, Frankenfield DL, Rocco MV, McClellan WM: Predictors of central venous catheter use at the initiation of hemodialysis. Semin Dial 2008; 21: 346-351.
20. Anton-Perez G, Perez-Borges P, Alonso-Alman F, Vega-Diaz N: Vascular accesses in haemodialysis: a challenge to be met. Nefrologia 2012; 32: 103-107.
21. Pisoni RL, Arrington CJ, Albert JM, Ethier J, Kimata N, Krishnan M, Rayner HC, Saito A, Sands JJ, Saran R, Gillespie B, Wolfe RA, Port FK: Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis 2009; 53: 475-491.
22. Perez-Garcia R, Martin-Malo A, Fort J, Cuevas X, Llados F, Lozano J, Garcia F; ANSWER Study: Baseline characteristics of an incident haemodialysis population in Spain: results from ANSWER-a multicentre, prospective, observational cohort study. Nephrol Dial Transplant 2009; 24: 578-588.
23. Gehan EA, George SL: Estimation of human body surface area from height and weight. Cancer Chemother Rep 1970; 54: 225-235.
24. Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL: Indices of relative weight and obesity. J Chron Dis 1972; 25: 329-343.
25. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31.
26. Lok CE, Allon M, Moist L, Oliver MJ, Shah H, Zimmerman D: Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol 2006; 17: 3204-3212. (Pubitemid 44707782)
27. Sidawy AN, Gray R, Besarab A, Henry M, Ascher E, Silva M Jr, Miller A, Scher L, Trerotola S, Gregory RT, Rutherford RB, Kent KC: Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg 2002; 35: 603-610. (Pubitemid 44718614)
28. Ravani P, Barrett B, Mandolfo S, Brunori G, Camcarini G, Imbasciati E, Malberti F: Factors associated with unsuccessful utilization and early failure of the arteriovenous fistula for hemodialysis. J Nephrol 2005; 18: 188-196. (Pubitemid 40852622)
29. Weyde W, Letachowicz W, Kusztal M, Porazko T, Krajewska M, Klinger M: Outcome of autogenous fistula construction in hemodialyzed patients over 75 years of age. Blood Purif 2006; 24: 190-195. (Pubitemid 43259173)
30. Astor BC, Eustace JA, Powe NR, Klag MJ, Sadler JH, Fink NE, Coresh J: Timing of nephrologist referral and arteriovenous access use: the CHOICE study. Am J Kidney Dis 2001; 38: 494-501. (Pubitemid 32803059)
31. Lee T, Barker J, Allon M: Associations with predialysis vascular access management. Am J Kidney Dis 2004; 43: 1008-1013. (Pubitemid 38691495)
32. Vassalotti JA, Jennings WC, Beathard GA, Neumann M, Caponi S, Fox CH, Spergel LM; Fistula First Breakthrough Initiative Community Education Committee: Fistula first breakthrough initiative: targeting catheter last in fistula first. Semin Dial 2012; 25: 303-310.
33. Moist LM, Trpeski L, Na Y, Lok CE: Increased hemodialysis catheter use in Canada and associated mortality risk: data from the Canadian Organ Replacement Registry 2001-2004. Clin J Am Soc Nephrol 2008; 3: 1726-1732.
34. Bradbury BD, Chen F, Furniss A, Pisoni RL, Keen M, Mapes D, Krishnan M: Conversion of vascular access type among incident hemodialysis patients: description and association with mortality. Am J Kidney Dis 2009; 53: 804-814.
35. Foley RN, Chen SC, Collins AJ: Hemodialysis access at initiation in the United States, 2005 to 2007: still 'catheter first'. Hemodial Int 2009; 13: 533-542.
36. Ng LJ, Chen F, Pisoni RL, Krishnan M, Mapes D, Keen M, Bradbury BD: Hospitalization risks related to vascular access type among incident US hemodialysis patients. Nephrol Dial Transplant 2011; 26: 3659-3666.
37. Perl J, Wald R, McFarlane P, Bargman JM, Vonesh E, Na Y, Jassal SV, Moist L: Hemodialysis vascular access modifies the association between dialysis modality and survival. J Am Soc Nephrol 2011; 22: 1113-1121.
38. Oliver MJ, Rothwell DM, Fung K, Hux JE, Lok CE: Late creation of vascular access for hemodialysis and increased risk of sepsis. J Am Soc Nephrol 2004; 15: 1936-1942. (Pubitemid 38822075)
39. Sands JJ: Increasing AV fistulae and decreasing dialysis catheters: two aspects of improving patient outcomes. Blood Purif 2007; 25: 99-102. (Pubitemid 46005758)
40. Lopot F, Nejedly B, Valek M: Vascular access monitoring: methods and procedures-something to standardize? Blood Purif 2005; 23: 36-44. (Pubitemid 40082242)